Perrigo (PRGO) Acquires ANDA for Generic Version Duac Gel From KV Pharmaceutical For $14M
Tweet Send to a Friend
Perrigo Company (Nasdaq: PRGO) announced that it has purchased the ANDA for clindamycin phosphate (1%) and benzoyl peroxide (5%) gel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
